Skip to main content

Advertisement

Table 1 Patients’ characteristics and clinical data

From: Increased expression of the interleukin-1 receptor-associated kinase (IRAK)-1 is associated with adipose tissue inflammatory state in obesity

Parameter Non-diabetic Diabetic
Lean Overweight Obese Lean Overweight Obese
Total number (N) 8 19 22 2 9 31
Male (N) 2 12 11 1 5 18
Female (N) 6 7 11 1 4 13
Age (years) 28–53 29–71 26–66 48–58 45–59 23–72
Body mass index (kg/m2) 23.035 ± 2.326 28.31 ± 1.081 34.383 ± 2.784 25.473 ± 0.338 28.130 ± 1.015 33.759 ± 2.561
Fat percentage (fat %) 29.757 ± 6.196 32.647 ± 4.998 39.011 ± 4.350 32.100 ± 6.223 33.050 ± 5.379 37.333 ± 5.035
Glucose (mmol/l) 5.096 ± 0.639 5.602 ± 1.559 5.424 ± 0.799 5.800 ± 0.424 8.578 ± 1.770 8.640 ± 2.930
Cholesterol (mmol/l) 5.313 ± 1.254 4.899 ± 0.773 5.233 ± 1.073 5.400 ± 2.546 4.816 ± 1.681 5.065 ± 1.236
High-density lipoprotein (mmol/l) 1.791 ± 0.477 1.219 ± 0.225 1.115 ± 0.235 1.135 ± 0.148 1.147 ± 0.411 1.129 ± 0.288
Low-density lipoprotein (mmol/l) 3.250 ± 1.046 3.147 ± 0.699 3.427 ± 0.942 3.700 ± 2.121 2.767 ± 1.391 3.013 ± 1.106
Triglycerides (mmol/l) 0.566 ± 0.216 1.215 ± 0.644 1.465 ± 0.821 1.245 ± 1.252 1.972 ± 0.880 1.913 ± 1.495
HbA1c (%) 5.688 ± 0.464 5.917 ± 1.65 5.863 ± 0.497 6.000 ± 0.283 7.544 ± 1.673 8.235 ± 1.506
Hypertension (N) 0 2 3 0 3 14
Hyperlipidemia (N) 0 0 2 0 2 3
Coronary artery disease (N) 0 0 1 0 1 1
Allergy (N) 0 0 1 0 0 2
Asthma (N) 0 1 0 0 0 3
Therapy   Nadolol, Lipitor, Aspirin Concor, Lipitor, Aspirin, Diovan Metfornin, Aspirin Glucophage, Lipitor, Lantus, Zocor, Diovan, Metformin, Aspirin NovoRapid, Lantus, Insulin, Aspirin, Concor, Zocor, Mixtard, Glucophage, Metformin, Capoten